OXYROW 50

OXYROW 50

  • Brand: Crowx Labs
  • Product Code: OXYROW 50
  • Availability: In Stock
  • $140.00



Manufacturer: Crowx Labs
Pharmaceutical name: Oxymetholone
Pack: 1 pack (100 tabs (50 mg))

OXYROW is an oral steroid that consists of 50 mg of the hormone Oxymetholone.

OXYROW 50 is highly effective for significantly enhancing both strength and size. It is extremely anabolic, leading to increased red blood cell production and a boost in appetite. Originally, OXYROW 50 was created as a treatment for individuals suffering from conditions that result in muscle wasting, such as HIV.

Many bodybuilders regard OXYROW 50 as the most potent oral steroid available for massive mass gain. It is essential to acknowledge that some of this weight increase may be due to water retention linked to the steroid. Although OXYROW is derived from DHT and does not convert directly to estrogen, it is still associated with various estrogen-related side effects. There are theories suggesting that OXYROW might stimulate the body’s natural estrogen receptors excessively. More potent anti-estrogens like Letrozole and Exemestane have proven effective in significantly lowering estrogen levels in the body, making them useful for minimizing these side effects during OXYROW use.

OXYROW 50 is a rapid-acting steroid, and bodybuilders typically start to observe its effects by the end of the first week. It is crucial to recognize that OXYROW can be harmful to the liver if not used responsibly. Bodybuilders are advised to limit cycles of this steroid to 6 weeks or fewer and to restrict daily doses to 100 mg or less.

Individuals planning to cycle with OXYROW 50 will often incorporate it during the initial 3-6 weeks of a cycle that also includes an injectable form of Testosterone. For even more significant mass gains, bodybuilders may opt to add another injectable, such as Deca or Tren, into the cycle. In such scenarios, the increases in mass and strength will likely be quite substantial. OXYROW 50 will suppress the body's natural testosterone production, making a post-cycle therapy (PCT) regimen essential after discontinuation of its use.